Instituto de Investigación Sanitaria y Biomédica de Alicante
Quick facts
Phase 3 pipeline
- Grup 2 dexametasona · Immunology
Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Instituto de Investigación Sanitaria y Biomédica de Alicante portfolio CI brief
- Instituto de Investigación Sanitaria y Biomédica de Alicante pipeline updates RSS
Frequently asked questions about Instituto de Investigación Sanitaria y Biomédica de Alicante
What is Instituto de Investigación Sanitaria y Biomédica de Alicante's pipeline?
Instituto de Investigación Sanitaria y Biomédica de Alicante has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Grup 2 dexametasona.
Related
- Sector hub: All tracked pharma companies